These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 78584)

  • 21. Simultaneous treatment of toxic diffuse goiter with I-131 and antithyroid drugs: a prospective study.
    Steinbach JJ; Donoghue GD; Goldman JK
    J Nucl Med; 1979 Dec; 20(12):1263-7. PubMed ID: 94089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment of toxic multinodular goiter].
    Fagel WJ; van der Vijver JC
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):252-3. PubMed ID: 2436063
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative curative effect of Mercasolyl and potassium perchlorate in treating patients with diffuse toxic goiter].
    Anvarova ShS
    Sov Med; 1972 Jul; 35(7):84-8. PubMed ID: 4115205
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of universal salt iodization on antithyroid drugs.
    Dai WX; Lian XL; Lu L; Li SM; Li SH; Li XW
    Chin Med J (Engl); 2006 Jul; 119(13):1108-12. PubMed ID: 16834930
    [No Abstract]   [Full Text] [Related]  

  • 26. [The condition of the reproductive system and menstrual function in patients with toxic goiter].
    Arsen'eva MG
    Sov Med; 1966 Jun; 29(6):125-7. PubMed ID: 4168473
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of susceptibility to pharmacologic treatment in Graves'-Basedow disease].
    Grzywa M; Maciejko-Meresta B
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):822-3. PubMed ID: 1726989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of succinate-containing preparations in combine therapy of diffuse toxic goiter].
    Iakubovskii SV; Kondratenko GG; Popova II
    Klin Med (Mosk); 2014; 92(8):50-3. PubMed ID: 25790698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G; Jie Y; Situ Y
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteocalcin in diffuse toxic goiter].
    Balabolkin MI; Khaiutina TL; Mkrtumian AM
    Ross Med Zh; 1992; (1):13-5. PubMed ID: 1377070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contemporary treatment of diffuse toxic goiter].
    Spesivtseva VG; Liashko KIa
    Sov Med; 1970; 33(8):103-11. PubMed ID: 4099132
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V; Voth E; Moka D; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of mercasolyl treatment of diffuse toxic goiter in children].
    Saakian RP
    Pediatriia; 1975 Jul; (7):14-6. PubMed ID: 55996
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of antithyroid drugs on the thyroid gland blood vessels in Basedow's disease].
    Yamasaki T
    Yonago Acta Med; 1966 Jul; 10(2):69-73. PubMed ID: 4167195
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J; Jaffiol C; Baldet L; Ghachem M
    Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diffuse toxic goiter].
    Starostina EG
    Feldsher Akush; 1992 Jan; 57(1):28-33. PubMed ID: 1383041
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current approaches to the treatment of diffuse toxic goiter].
    Balabolkin MI
    Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
    [No Abstract]   [Full Text] [Related]  

  • 40. [Some recent progress in the medical treatment of hyperthyroidism].
    Bricaire H; Joly J
    Presse Med (1893); 1967 Jun; 75(29):1517-21. PubMed ID: 4165247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.